181 participants
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-26
- Start Date:
- 2020-12-02
- Completion:
- 2021-05-25
Conditions
- Covid19
Interventions
- DRUG